Improving diagnosis of legume allergy in kids
Part of Immune system & allergy clinical trials.
This study looks at better ways to diagnose allergies to legumes like lupine, fenugreek, and peas in children. If your child is allergic to these foods, this trial may help find more accurate testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a known sensitization to lupine, fenugreek, or pea.
- Your child must not be currently taking an anti-IgE medication or have taken one in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how quickly children with possible egg and/or milk allergy are correctly diagnosed, and how follow-up checks affect their nutrition and growth. It may help you understand whether timely diagnosis and good monitoring could reduce problems with eating, weight, or growth.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study compares different tests to diagnose legume allergies. They look at skin prick tests, blood tests for IgE antibodies, and component-resolved diagnosis to see which works best for peas, lentils, chickpeas, and beans.
This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.
This study is observing children with food allergies who are willing to do an oral food challenge (eating the allergen in a safe clinic setting). It helps doctors learn more about how allergies affect children.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
Hear when a new Food Allergy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.